当前位置：首页 > 文献互助 > 互助详情

A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells复制

用户MiTCsb6qQkVQ 14天前 30 10 已关闭

DOI: 10.1038/s41375-025-02647-x复制

文献链接: https://www.nature.com/articles/s41375-025-02647-x复制

其他信息:

出版社: Springer Science and Business Media LLC
作者: Shi Feng; Ran Kong; Cong Wang; Qingbo Hao; Xiaoyu Xie; Haiyang Wang; Jingjing Han; Yu Zhang; Jan Elsner; Derek Mendy; Michael Haughey; Paul Krenitsky; Veronique Plantevin-Krenitsky; Patrick Papa; Frank Mercurio; Weilin Xie; Xiangxiang Zhou
全文下载地址: https://www.nature.com/articles/s41375-025-02647-x.pdf

上一篇：Selective and Potent Molecular Glue Degraders for NIMA-Related Kinase 7

下一篇：FDA approves 100th small-molecule kinase inhibitor

互助时间线

2025-11-17 14:56:38 [关闭求助]

楼主用户MiTCsb6qQkVQ关闭了求助

2025-11-17 14:22:26 [发起求助]

最新发布的求助

Index Structures for Biological Sequences 3小时前
Drugging the efferocytosis process: concepts and opportunities. 4小时前
Characterization of CAR-T cellular kinetics and efficacy in solid tumor patients with and without prior lymphodepletion chemotherapy using a PBPK-PD model 5小时前
Comprehensive 3d Transition Metal Single‐Atom Modulation Tunes Ni‐MOF D‐Band for Alkaline OER 6小时前
Decoupling of nitrogen, phosphorus, and carbon release from fine and coarse roots during 7 years of decomposition 6小时前
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure 6小时前
Tetrahedral Framework Nucleic Acid-Based Delivery of miR-34a Inhibitor for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. 7小时前
A practical guide to large-scale docking 7小时前
Bicyclo[1.1.1]pentane-Derived Building Blocks for Click Chemistry 7小时前
Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review 8小时前
{Formulated Preparations- Specific Monographs} Rivastigmine Capsules - british pharmacopoeia[1731412457.779041.html] 9小时前
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China 10小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com